Allergen Avoidance in Allergic Asthma

Francesca Cipriani1, Elisabetta Calamelli1,2, Giampaolo Ricci1

  • 1Pediatric Unit, S. Orsola-Malpighi Hospital, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Insights

Preventing allergic asthma in children involves controlling indoor allergen exposure. While evidence is debated, allergen avoidance remains a recommended strategy for managing respiratory symptoms.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Respiratory Medicine

Background:

  • Allergic asthma is a prevalent chronic respiratory condition in children, significantly impacting public health.
  • Effective preventive strategies are crucial for managing symptoms and improving long-term outcomes in pediatric asthma patients.
  • Indoor allergen exposure is a primary trigger for allergic asthma, necessitating targeted control interventions.

Purpose of the Study:

  • To review recent literature on the efficacy of specific interventions for controlling major indoor allergens in allergic asthma.
  • To evaluate the evidence supporting various allergen control methods for sensitized individuals with respiratory allergies.

Main Methods:

  • Systematic literature review of studies investigating indoor allergen control interventions for allergic asthma.
  • Analysis of evidence regarding the effectiveness of allergen avoidance and reduction strategies.

Main Results:

  • A wide range of interventions exist to reduce indoor allergen exposure for sensitized patients.
  • Current evidence supporting the efficacy of these specific allergen control approaches is limited and often controversial.
  • Despite weak evidence, allergen exposure control is generally recommended as part of a comprehensive asthma management plan.

Conclusions:

  • Allergen avoidance is a cornerstone of managing allergic asthma, particularly in pediatric populations.
  • Further research is needed to establish definitive evidence for the effectiveness of specific indoor allergen control measures.
  • A holistic approach, including allergen control, is vital for reducing the severity of allergic respiratory symptoms.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K